"Mastocytosis, Systemic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.
Descriptor ID |
D034721
|
MeSH Number(s) |
C04.557.450.565.465.750 C20.543.520.350.750
|
Concept/Terms |
Mastocytosis, Systemic- Mastocytosis, Systemic
- Mastocytoses, Systemic
- Systemic Mastocytoses
- Systemic Mastocytosis
- Systemic Mast-Cell Disease
- Mast-Cell Disease, Systemic
- Mast-Cell Diseases, Systemic
- Systemic Mast Cell Disease
- Systemic Mast-Cell Diseases
Aggressive Systemic Mastocytosis- Aggressive Systemic Mastocytosis
- Aggressive Systemic Mastocytoses
- Mastocytoses, Aggressive Systemic
- Mastocytosis, Aggressive Systemic
- Systemic Mastocytoses, Aggressive
- Systemic Mastocytosis, Aggressive
Indolent Systemic Mastocytosis- Indolent Systemic Mastocytosis
- Indolent Systemic Mastocytoses
- Mastocytoses, Indolent Systemic
- Mastocytosis, Indolent Systemic
- Systemic Mastocytoses, Indolent
- Systemic Mastocytosis, Indolent
|
Below are MeSH descriptors whose meaning is more general than "Mastocytosis, Systemic".
Below are MeSH descriptors whose meaning is more specific than "Mastocytosis, Systemic".
This graph shows the total number of publications written about "Mastocytosis, Systemic" by people in this website by year, and whether "Mastocytosis, Systemic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 3 | 0 | 3 |
2018 | 1 | 2 | 3 |
2019 | 2 | 1 | 3 |
2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Mastocytosis, Systemic" by people in Profiles.
-
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis. J Allergy Clin Immunol. 2021 03; 147(3):877-878.
-
No evidence of vertical transmission of SARS-CoV-2 after induction of labour in an immune-suppressed SARS-CoV-2-positive patient. BMJ Case Rep. 2020 Jun 30; 13(6).
-
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions. J Allergy Clin Immunol. 2020 08; 146(2):300-306.
-
Detection of KIT D816V mutation in patients with severe anaphylaxis and normal basal tryptase-first data from the Anaphylaxis Registry (NORA). J Allergy Clin Immunol. 2019 11; 144(5):1448-1450.e1.
-
Image Gallery: The vulva: an atypical localization of mastocytosis in adulthood. Br J Dermatol. 2019 08; 181(2):e33.
-
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome. J Allergy Clin Immunol Pract. 2019 04; 7(4):1125-1133.e1.
-
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry. Future Oncol. 2018 11; 14(26):2713-2723.
-
De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child. Diagn Pathol. 2018 Feb 20; 13(1):14.
-
Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms. Leuk Res. 2018 04; 67:67-74.
-
Development of tripe palms and soles in a patient with long pre-existing systemic mastocytosis and newly developed non-small cell lung cancer. J Eur Acad Dermatol Venereol. 2018 Apr; 32(4):e151-e153.